Concepedia

Victoria Parker

VP

15

Publications

1.6K

Citations

13

H-Index

1997

Active since

Affiliations

University of Cambridge(Current)

AstraZeneca (United Kingdom)

University College London

University of Edinburgh

CHU Dijon Bourgogne

Victoria Parker is an author at University of Cambridge specializing in medicine, molecular genetics, and genetics.

ORCID

Top concepts

Publications per year

1997–2024

15

Publications

15

<i>PIK3CA</i>‐related overgrowth spectrum (PROS): Diagnostic and testing eligibility criteria, differential diagnosis, and evaluation

Kim M. Keppler‐Noreuil, Jonathan J. Rios, Victoria Parker et al. · American Journal of Medical Genetics Part A · 2014 · 541 citations · Full text

Mosaic RAS/MAPK variants cause sporadic vascular malformations which respond to targeted therapy

Lara Al-Olabi, Satyamaanasa Polubothu, Katherine Dowsett et al. · Journal of Clinical Investigation · 2018 · 276 citations · Full text

Somatic activating mutations in <i>Pik3ca</i> cause sporadic venous malformations in mice and humans

Sandra D. Castillo, Elena Tzouanacou, May Zaw Thin et al. · Science Translational Medicine · 2016 · 182 citations · Full text

Safety and efficacy of low-dose sirolimus in the PIK3CA-related overgrowth spectrum

Victoria Parker, Kim M. Keppler‐Noreuil, Laurence Faivre et al. · Genetics in Medicine · 2018 · 150 citations · Full text

Monoallelic and Biallelic Mutations in MAB21L2 Cause a Spectrum of Major Eye Malformations

Joe Rainger, Davut Pehli̇van, Stefan Johansson et al. · The American Journal of Human Genetics · 2014 · 89 citations · Full text

, , +10

Rows per page

1–5 of 15